Keywords
Rheumatology
Joints
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the characteristics of Rheumatoid Arthritis (RA). Bibliographic review: RA affects about 0.5% and 1% of the world population, with a predominance of 3 times more in females than in males. The main symptoms of RA are pain, inflammation, swelling and stiffness of the synovial joints. However, the body-wide symptoms of this disease can include tiredness, high temperature, weight loss, and loss of appetite. RA has a strong genetic component, however there are environmental exposure factors such as exposure to tobacco smoke. Treatment can be performed with Metrotexate, which changes the natural history of the disease, in addition to non-steroidal and immunobiological anti-inflammatory drugs. Final considerations: RA is a chronic autoimmune disease that affects the joints, characterized by progressive symmetrical inflammation of the affected joints, resulting in cartilage destruction, bone erosion and functional disability. It can also be mentioned that there are extra-articular manifestations such as increased cardiovascular risk, kidney damage, gastrointestinal alterations and eye damage. In this sense, it is essential to understand the disease in order to provide an adequate diagnosis and treatment.
References
ACHARYA M, DAVE A. Commentary: Corneal involvement in rheumatoid arthritis. Indian J Ophthalmol, 2021; 69(1): 73-74.
ANDRADE TF, DIAS SRC. Etiologia da artrite reumatoide: revisão bibliográfica. Braz. J. Hea. Rev, 2019; 2(4): 3698-718.
CAVALCANTE AFS, et al. Gynecological/Obstetric Background and Rheumatoid Arthritis: A Cross-sectional Study in Brazilian Patients. Revista Brasileira de Ginecologia e Obstetrícia; 2021; 43(05): 357-361.
CHEBOTAREVA NV, et al. Renal lesions in rheumatoid arthritis: Variants and risk factors. Saudi J Kidney Dis Transpl, 2021 Mar; 32(2): 588-589.
CHOY EH, DURES E. Fatigue in rheumatoid arthritis. Rheumatology (Oxford). 2019; 58(5): 1-2.
CRAIG E, CAPPELLI LC. Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis. Rheum Dis Clin North Am, 2018; 44(1):89-111.
CRAMP F. The role of non-pharmacological interventions in the management of rheumatoid-arthritis-related fatigue. Rheumatology (Oxford), 2019; 58(5): 22-28.
ENGLAND BR, et al. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ, 2018; 361: k1036.
GERMANO JL, et al. Prevalência da artrite reumatoide na América do Sul: revisão sistemática e meta-análise. Ciência & Saúde Coletiva, 2021; 26(3): 5371-5382.
HUANG J, et al. Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis. Front Immunol. 2021; 12: 686155.
HULEN E, et al. Patient goals in rheumatoid arthritis care: A systematic review and qualitative synthesis. Musculoskeletal Care, 2017; 15(4): 295-303.
JANG S, et al. Rheumatoid Arthritis: Pathogenic Roles of Diverse Immune Cells. Int J Mol Sci, 2022; 23(2): 905.
KRONZER VL, DAVIS JM. Etiologies of Rheumatoid Arthritis: Update on Mucosal, Genetic, and Cellular Pathogenesis. Curr Rheumatol Rep, 2021; 23(4): 21.
LIN YJ, et al. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells, 2020; 9(4): 880.
LOPEZ-PEDRERA C, et al. Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis. Int J Mol Sci, 2020; 21(23): 9067.
MACFARLANE FR, et al. Quantitative Predictive Modelling Approaches to Understanding Rheumatoid Arthritis: A Brief Review. Cells, 2019; 9(1): 74.
MEYER PW, et al. Rheumatoid arthritis and risk of cardiovascular disease. Cardiovasc J Afr, 2018; 29(5): 317-321.
RIADH EM, et al. Immunologic Parameters for Disease Activity in Rheumatoid Arthritis. Arch Razi Inst, 2021; 76(4):1095-1105.
SCHERER HU, et al. The etiology of rheumatoid arthritis. J Autoimmun, 2020; 110:102400.
YAN H, et al. Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response. Front Immunol, 2021; 12: 789334.
YIP K, NAVARRO-MILLÁN I. Racial, ethnic, and healthcare disparities in rheumatoid arthritis. Curr Opin Rheumatol, 2021; 33(2):117-121.
ZHANG A, LEE YC. Mechanisms for Joint Pain in Rheumatoid Arthritis (RA): from Cytokines to Central Sensitization. Curr Osteoporos Rep, 2018; 16(5): 603-610.
ZHAO J, et al. Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications. Front Immunol, 2021; 12: 790122.
ZULFIQAR AA, et al. Rheumatoid arthritis and cardiovascular risk factor: literature review. Rev Med Liege, 2018; 73(12): 634-639.